News Gubra A/S

Equities

GUBRA

DK0062266474

Real-time Estimate Cboe Europe Other stock markets 06:02:47 2024-05-13 am EDT			5-day change	1st Jan Change
320.5 ^DKK	-5.18%		+6.67%	+156.00%

Apr. 17	Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss	CI
Mar. 29	Certain Shares of Gubra A/S are subject to a Lock-Up Agreement Ending on 29-MAR-2024.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss	Apr. 17	CI
Certain Shares of Gubra A/S are subject to a Lock-Up Agreement Ending on 29-MAR-2024.	Mar. 28	CI
Gubra Concludes the Research Agreement with Silence Therapeutics plc	Jan. 26	CI
Gubra and Boehringer Ingelheim Sign 4Th Partnership, Expanding Their Successful Obesity Treatment Discovery Collaboration	Dec. 13	CI
Gubra A/S Announces First Subject Dosed in Phase 1 Clinical Trial of Amylin Agonist for the Treatment of Obesity	Nov. 29	CI
Gubra A/S Announces Board Appointments	Nov. 01	CI
Gubra Raises Earnings Guidance for Full-Year 2023	23-10-26	CI
Denmark's Gubra Opens First US Office Under Expansion Strategy	23-10-24	MT
Gubra A/S Opens Its First US Office in Boston	23-10-24	CI
Gubra Seeks UK Regulatory Approval to Begin Human Trial for Anti-Obesity Drug	23-09-06	MT
Gubra A/S Submits Clinical Trial Application for First-In-Human Amylin Trial	23-09-06	CI
Tranche Update on Gubra A/S's Equity Buyback Plan announced on June 30, 2023.	23-08-25	CI
Gubra Announces Termination of Collaboration with Bayer AG	23-08-23	CI
Gubra A/S Raises Financial Guidance for Full-Year 2023	23-08-15	CI
Gubra A/S commences an Equity Buyback Plan for 1,180,424 shares, under the authorization approved on March 16, 2023.	23-06-30	CI
Gubra A/S acquired Minigut Aps for DKK 5.96 million.	23-06-28	CI
Gubra A/S Announces Updates to Its Pipeline	23-06-09	CI
Gubra A/S and Boehringer Ingelheim Share Phase 1 Results for BI 1820237	23-05-17	CI
Gubra A/S Provides Revenue Guidance for the Year 2023	23-05-11	CI
Danish Biotech Gubra's IPO Overallotment Option Partly Exercised	23-05-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Gubra A/S

Equities

GUBRA

DK0062266474

Summary

Filters